Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740331015 | Fosaprepitant only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3740332010 | Product containing only fosaprepitant in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4527501000052110 | läkemedel som endast innehåller fosaprepitant, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fosaprepitant only product in parenteral dose form | räkning av bas i aktiv ingrediens | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Fosaprepitant only product in parenteral dose form | Is a | Fosaprepitant only product | true | Inferred relationship | Some | ||
| Fosaprepitant only product in parenteral dose form | Has active ingredient | Fosaprepitant (substance) | true | Inferred relationship | Some | 1 | |
| Fosaprepitant only product in parenteral dose form | Is a | Product containing fosaprepitant in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Fosaprepitant only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Fosaprepitant only product in parenteral dose form | Plays role | Antiemetic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial | Is a | True | Fosaprepitant only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR